ATRX and oligodendroglioma: Though IDH1/2-mutant oligodendrogliomas had frequent alterations in TERT promoter (94.3%) and CIC (69.1%), there remained a low prevalence of TP53 (7.5%) and ATRX (6.4%) alterations.